Joseph A. Markey

President & Chief Executive Officer at Integrated Resource Recovery, Inc.

Joseph A. Markey

Joseph A. Markey

President & Chief Executive Officer at Integrated Resource Recovery, Inc.

Overview
Career Highlights

Integrated Resource Recovery, Inc.

RelSci Relationships

29

Number of Boards

1

Relationships
RelSci Relationships are individuals Joseph A. Markey likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Professional at Browning-Ferris Industries, Inc.

Relationship likelihood: Strong

Chief Technology Officer at Triumvirate Environmental (Florida), Inc.

Relationship likelihood: Strong

Director at Integrated Resource Recovery, Inc.

Relationship likelihood: Strong

Executive Officer at Integrated Resource Recovery, Inc.

Relationship likelihood: Strong

Executive Chairman & Chief Executive Officer at TheraVida, Inc.

Relationship likelihood: Average

Former Vice President-Bioprocessing at Valentis, Inc.

Relationship likelihood: Average

Former Chief Business Officer at Imprimis Pharmaceuticals, Inc.

Relationship likelihood: Average

Former Chief Financial Officer & Director at Urigen Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Chairman at Update Pharma, Inc.

Relationship likelihood: Average

Former President & Chief Executive Officer at Morris Animal Foundation

Relationship likelihood: Average

Paths to Joseph A. Markey
Potential Connections via
Relationship Science
You
Joseph A. Markey
President & Chief Executive Officer at Integrated Resource Recovery, Inc.
Career History
President & Chief Executive Officer
Tenure Unconfirmed
Vice President-Finance & Administration
Prior - 2006

Valentis lead drug candidate, Deltavasc, may treat peripheral arterial and ischemic heart disease with a gene that spurs new blood vessels to form (a process known as angiogenesis). In early stages of development are DNA vaccines for HIV, hepatitis C, and other viral infections. Another drug candidate, eNOS, could prevent tissue rejection in transplant recipients. The company licenses its technology -- include the GeneSwitch platform, which can turn off or on gene therapies -- to other drugmakers. These licensees include Genzyme, Pfizer, and GlaxoSmithKline.

Boards & Committees
Director
Tenure Unconfirmed
Transactions
Details Hidden

Integrated Resource Recovery, Inc. raised money in a private placement transaction

Details Hidden

Integrated Resource Recovery, Inc. raised money in a private placement transaction

Details Hidden

Integrated Resource Recovery, Inc. raised money in a private placement transaction

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joseph A. Markey. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joseph A. Markey's profile does not indicate a business or promotional relationship of any kind between RelSci and Joseph A. Markey.